Yearly Archives: 2022

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Paroxetine (Seroxat®) 20mg/10ml oral suspension. MSN/2022/063 Tier 2 – medium impact Date of issue 14th July 2022 Paroxetine (Seroxat®) 20mg/10ml oral suspension will be discontinued in July 2022 There are limited supplies remaining. Paroxetine tablets and unlicensed specials of paroxetine 10mg/5ml [...]

The post Medicine Supply Notification: Paroxetine (Seroxat®) 20mg/10ml oral suspension appeared first on PSNC Website.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Alendronic acid 70mg tablets. MSN/2022/062 Tier 2 – medium impact Date of issue 14th July 2022 Alendronic acid 70mg tablets are out of stock until late-August 2022. Risedronate sodium 35mg tablets (weekly) and ibandronic acid 150mg tablets (monthly) remain available. Where [...]

The post Medicine Supply Notification: Alendronic acid 70mg tablets appeared first on PSNC Website.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for: Buserelin (Suprefact®) 5.5mg/5.5ml solution for injection vials Buserelin (Suprecur®) 5.5mg/5.5ml solution for injection vials  Buserelin (Suprecur®) 150microgram/dose nasal spray MSN/2022/061 Tier 2 – medium impact Date of issue 11th July 2022 Buserelin (Suprefact®) 5.5mg/5.5ml solution for injection vials are out of [...]

The post Medicine Supply Notification: Suprefact and Suprecur appeared first on PSNC Website.

New resources have been published for pharmacists and pharmacy technicians to help them fulfil the duty of candour - the professional responsibility to be open and honest with patients when something goes wrong  

RPS and the General Pharmaceutical Council (GPhC) have today published an updated joint statement highlighting the importance of regulatory and professional standards and guidance to ensure patient-centred, safe and effective care.